Category Archives: Cardiology

The Handoff: Your Week in Cardiology News - 3/10/17 The Cardiology Advisor (registration) The Handoff is a weekly roundup of cardiology news covering various developments in subspecialties, as well as pharmaceutical industry, association, and ... and more » Here is the original post: The Handoff: Your Week in Cardiology News - 3/10/17 - The Cardiology Advisor (registration) … Continue reading →

Highly-Skilled Cardiologists Bring World Class Cardiac Care to Rockland and Bergen Counties PRESS RELEASECardiologistsPerminder S. Grewal, MD, FACC, Arvind K. Agarwal, MD, FACC, Bangalore S. Sridhara, MD, FACC, MRCP, Sunandan A. Pandya, MD, FACC, Shital R. Parikh, MD, FACC, and Rajiv Singh, MD, FACC, have joined Bon Secours Medical Group. This highly skilled group, with offices in West Nyack, Stony Point and Ramsey, NJ, brings world class cardiac care to the local community. Dr. Perminder S. Grewal has been practicing cardiology for 30 years. He currently serves as Director of Cardiology Consultants of Rockland in Stony Point, NY, Director of the Bergen Heart Center LLC, in Ramsey, NJ, Director of Outreach and Business Development at Hackensack University Medical Center in Hackensack, NJ, and is the Vice Chairman of Cardiology at Hackensack University Medical Center North in Pascack, NJ. He has previously served as Chief of Cardiology, President of Medical Staff and as a member of the Board of Trustees at Nyack Hospital. He completed his medical degree at Christian Medical College in Ludhiana, India, his residency at the Albert Einstein College of Medicine in the Bronx, NY, and his fellowship at New York Medical College System in Valhalla, NY. He … Continue reading →

American College of Cardiology 2017 Preview The Cardiology Advisor (registration) The 2017 American College of Cardiology (ACC) 66th Scientific Session & Expo will take place from Friday, March 17, through Sunday, March 19, in Washington, DC. This year, the ACC accepted 23 late-breaking clinical trials, 17 of which were accepted as ... See the original post here: American College of Cardiology 2017 Preview - The Cardiology Advisor (registration) … Continue reading →

Updated 2 minutes ago A Connecticut cardiologist testified Wednesday that as many as five stents implanted into a North Huntingdon truck driver in late 2008 were unnecessary and led to complications that nearly cost Steven Sensenich his life. During the third day in a malpractice trial, Dr. John Setaro told jurors that medical evidence did not support the decision by Dr. Ehab Morcos to perform two separate procedures at Excela Health Westmoreland Hospital. There was no need for more invasive procedures as there were no (health) indications and no benefits, Setaro said. A Westmoreland County jury is hearing evidence in lawsuit brought by Sensenich against Morcos, Westmoreland County Cardiology, his cardiac practice, and Excela that alleges unnecessary medical procedures. The trial is the first of 71 cases pending against Excela, Morcos and Dr. George Bou Samra that were filed after the hospital issued 192 disclosures to patients who were suspected to have received unnecessary stents from the doctors in 2009 and 2010. Sensenich was not part of that disclosure, but he contends Morcos recommended and performed three procedures to implant unneeded stents, mesh tubes that increase blood flow in cardiac arteries. Setaro reviewed Sensenich's medical records and narrated to jurors … Continue reading →

As the population ages, we continue to see more patients diagnosed with atrial fibrillation. Some are even calling the increase in atrial fibrillation diagnoses an epidemic. Frequently, these patients require chronic oral anticoagulation. For decades, we have use vitamin K antagonists such as warfarin. Due to complex monitoring and dosage adjustments, drug interactions and potential side effects such as hemorrhagic stroke and gastrointestinal bleeding, patients and providers have always hoped an alternative to warfarin would come along. Over the last few years, a multitude of target specific oral anticoagulants (TSOACs) for treatment of nonvalvular atrial fibrillation have been approved. These new medications range from direct thrombin inhibitors to Factor Xa inhibitors. TSOACs are not without their drawbacks (bleeding, lack of a specific antidote for some), but for many, they are a significant advance over warfarin. To aid providers caring for patients on anti-platelet and anticoagulants, the American College of Cardiology (ACC) has been producing some outstanding apps. Previously on iMedicalApps we reviewed their outstanding Anticoag Evaluator and DAPT calculator apps. An additional resource is the excellent MAQI2 Anticoagulation Toolkit from the University of Michigan and insurer Blue Cross Blue Shield. How should providers handle patients with nonvalvular atrial fibrillation on … Continue reading →

NEW YORK, March 6, 2017 /PRNewswire/ -- Interventional cardiology specifically deals with the catheter based treatment of cardiovascular and structural heart diseases. Products of interventional cardiology market are Catheters, Interventional Diagnostic Catheters, stents, valves, transcatheter heart pump and others. Catheters are segmented into Guide Catheter, Balloon Catheter, Atherectomy Catheters, Thrombectomy Catheters, and Ablation Catheters. Read the full report: http://www.reportlinker.com/p04756645-summary/view-report.html Interventional Diagnostic Catheters are segmented into Intravascular ultrasound (IVUS), Fractional flow reserve (FFR), Optical coherence tomography (OCT), Angiograph, Pulmonary artery catheter, Electrophysiology catheter. Stents are further categorised into bare metal stents, drug eluting stents, Bioresorbable stents and Stent grafts. Valves are further divided into Transcatheter Aortic Valve, Annuloplasty Ring, Mitral Clip, and Valvuloplasty. Others are segmented into closure devices (Occluders), Inferior vena cava filters, Guide wires, Transcatheter pacemaker, and accessories. Applications of Interventional cardiology market are segmented into Diagnostic catheterization, Coronary Interventions, Peripheral interventions and Structural Heart. Coronary intervention application is sub-segmented into Aortic aneurysm (EAVR, TEVAR), Coronary Thrombectomy, PCTA, Coronary Cardiac Ablation and others. Peripheral interventions are sub-segmented into Peripheral Aneurysm, Peripheral Thrombectomy, Peripheral Angioplasty, Peripheral Ablation, Pulmonary embolism, and others. Structural heart is further sub-segmented into Valve replacement, Valve repair, Heart Assist Device, Congenital heart defect and others. The … Continue reading →

Donald Lloyd-Jones, MD, senior associate dean for Clinical and Translational Research and chair of Preventive Medicine, will receive the receive The American Society for Preventive Cardiologys 2017 Joseph Stokes, III, MD Award. Donald Lloyd-Jones, MD, ScM, senior associate dean for Clinical and Translational Research and chair of Preventive Medicine, has been selected to receive the 2017 Joseph Stokes, III, MD Award from the American Society for Preventive Cardiology (ASPC) for his achievements in preventive cardiology. Presented annually, the award commemorates Joseph Stokes III, MD, a physician who contributed to the fields of cardiology and epidemiology as well as to the ASPC. I am truly honored to receive the Joseph Stokes, III, MD Award, and it is profoundly humbling to join such a prestigious list of prior awardees, said Lloyd-Jones. The Stokes Award is especially meaningful to me as it has previously been awarded to a number of my mentors, including Bill Kannel in 2011, with whom I worked at Framingham, and Jerry Stamler in 2012, Phil Greenland in 2002, and Darwin Labarthe in 2006, who are all current faculty here in our Department of Preventive Medicine at Feinberg. Lloyd-Jones will be presented with the award during the Epi-Lifestyle Meeting on … Continue reading →

IQ4I Research & Consultancy Published a New Report on Interventional Cardiology Global Market Forecast to 2023 Interventional cardiology deals with catheter based less invasive techniques for treatment of various cardiovascular diseases, the changing demography, increasing lifestyle disease are increasing the demand for less invasive, cost effective procedures. Boston, MA, March 06, 2017 (PR.com) Interventional cardiology deals with the catheter based techniques for the treatment of cardiovascular diseases such as coronary and peripheral artery diseases, valvular and congenital heart diseases and structural heart diseases. As estimated by IQ4I Research the interventional cardiology global is expected to grow at high single digit CAGR to reach $46,124.1 million by 2023. The Interventional cardiology global market by products is segmented into catheters, stents, valves, interventional diagnostic devices, transcatheter heart pump and others. Interventional cardiology market by applications includes diagnostic catheterization, coronary interventions, peripheral interventions and structural heart. Among the products stents held the highest share due to wide acceptance of stent procedures, a minimal invasive surgery with less risk of complications than open surgery. Transcatheter heart pump segment is project to grow at a very high double digit CAGR. Abiomed, U.S. based medical device company has developed worlds smallest catheter based heart pump that … Continue reading →

MENAFN Press - 05/03/2017 (MENAFN Editorial) -- Interventional cardiology deals with the catheter based techniques for the treatment of cardiovascular diseases such as coronary and peripheral artery diseases, valvular and congenital heart diseases and structural heart diseases. Interventional cardiology market is growing at a steady rate, as estimated by IQ4I Research the interventional cardiology global is expected to grow at high single digit CAGR to reach 46,124.1 million by 2023. Increase in prevalence of cardiovascular disorders due to rise in aging population, increasing number of interventional procedures, rise in the number of clinical studies performed, increasing prevalence of lifestyle diseases are some of the drivers of the market. Technology advancements and growing healthcare budgetary allocation, growth in emerging countries, and increase in patient awareness for minimal invasive surgeries are some of the opportunities that are propelling the growth of the market. However, lack of skilled and trained professionals and reimbursement issues in emerging countries are some of the restraints of the market. Stringent regulatory requirements with high cost of development and availability of alternate products are some of the threats of the market. The Interventional cardiology global market by products is segmented into catheters, stents, valves, interventional diagnostic devices, transcatheter … Continue reading →

Head of Ukraine's State Fiscal Service Roman Nasirov has been transported to M.D.Strazhesko Institute of Cardiology. TV Channel "112 Ukraine" broadcasts the event. MPs came to the medical institution. The press service of the National Anti-Corruption Bureau of Ukraine (NABU) has reported that Nasirov was transported to another hospital with the purpose of confirming his diagnosis. As reported, Nasirov is suspected of abuse of office and embezzlement of public funds in the amount of over UAH 2 billion. March 2, the National Anti-corruption Bureau of Ukraine (NABU) and the Special Anti-corruption Prosecutor's Office of Ukraine (SAPU) held a number of raids in the State Fiscal Service's offices. Roman Nasirov is charged under Article 364 of the Criminal Code of Ukraine (the abuse of power or official position). NABU suspects that the installment plan for rent payments for gas production, which had been approved by the State Fiscal Service, was part of the scheme by MP Oleksandr Onyshchenko's firms on misappropriation of funds PJSC Ukrgasvydobuvannia in the amount of UAH 740.07 million. ish Follow this link: Nasirov transported to M.D. Strazhesko Institute of Cardiology ... - Ukrinform. Ukraine and world news … Continue reading →